Stock analysts at MED assumed coverage on shares of Gardner Denver (NYSE:GDI) in a note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $36.00 price target on the stock. MED’s price target would suggest a potential upside of 24.87% from the stock’s current price.
GDI has been the subject of a number of other research reports. ValuEngine lowered shares of Gardner Denver from a “hold” rating to a “sell” rating in a research note on Monday, April 2nd. Zacks Investment Research raised shares of Gardner Denver from a “hold” rating to a “buy” rating and set a $36.00 price objective for the company in a research note on Wednesday, April 18th. Citigroup raised their price objective on shares of Gardner Denver from $41.00 to $42.00 and gave the stock a “buy” rating in a research note on Monday, April 30th. Finally, Johnson Rice raised shares of Gardner Denver from an “accumulate” rating to a “buy” rating in a research note on Friday, June 15th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $34.55.
NYSE:GDI traded down $0.44 during trading hours on Wednesday, reaching $28.83. 1,313,938 shares of the company’s stock were exchanged, compared to its average volume of 1,157,307. The stock has a market capitalization of $5.85 billion and a price-to-earnings ratio of 288.30. Gardner Denver has a 12 month low of $21.73 and a 12 month high of $38.00. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.55 and a current ratio of 2.48.
In other Gardner Denver news, major shareholder Fund Holdings L.P. Kkr sold 30,436,064 shares of the stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $29.84, for a total value of $908,212,149.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.70% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Gardner Denver by 123.7% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,793 shares of the company’s stock worth $147,000 after buying an additional 2,650 shares in the last quarter. Metropolitan Life Insurance Co. NY lifted its position in Gardner Denver by 50.2% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 4,850 shares of the company’s stock worth $165,000 after buying an additional 1,620 shares in the last quarter. US Bancorp DE lifted its position in Gardner Denver by 341.2% in the 1st quarter. US Bancorp DE now owns 5,210 shares of the company’s stock worth $160,000 after buying an additional 4,029 shares in the last quarter. Virtu Financial LLC purchased a new stake in Gardner Denver in the 4th quarter worth approximately $245,000. Finally, The Manufacturers Life Insurance Company lifted its position in Gardner Denver by 38.5% in the 1st quarter. The Manufacturers Life Insurance Company now owns 8,229 shares of the company’s stock worth $253,000 after buying an additional 2,286 shares in the last quarter. Institutional investors own 98.76% of the company’s stock.
Gardner Denver Company Profile
Gardner Denver Holdings, Inc provides mission-critical flow control and compression equipment; and associated aftermarket parts, consumables, and services in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Industrials, Energy, and Medical.
Receive News & Ratings for Gardner Denver Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gardner Denver and related companies with MarketBeat.com's FREE daily email newsletter.